-+ 0.00%
-+ 0.00%
-+ 0.00%

Relmada Therapeutics raises authorized common shares to 200 million from 150 million

PUBT·05/28/2026 21:01:50
Listen to the news
Relmada Therapeutics raises authorized common shares to 200 million from 150 million
  • Relmada Therapeutics filed a Nevada charter amendment raising authorized common shares to 200,000,000 from 150,000,000.
  • Stockholders cleared the increase at the 2026 annual meeting on May 27; the filing was made May 28, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-062184), on May 28, 2026, and is solely responsible for the information contained therein.